UMIN ID: UMIN000001498
Registered date:12/11/2008
Phase II study of TS-1 chemotherapy as adjuvant treatment after resection of hepatic metastases from colorectal cancer
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | liver metastases of colorectal cancer |
| Date of first enrollment | 2008/10/01 |
| Target sample size | 60 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | TS-1 chemotherapy as adjuvant treatment |
Outcome(s)
| Primary Outcome | disease free survival |
|---|---|
| Secondary Outcome | overall survival, side effect |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 80years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | (1) Prior chemotherapy with TS-1 (2) Multiple cancer (3) Severe complication (4) Active diarrhea (5) Prebious history of severe drug-induced allergy (6) Pregnant (7) Disqualified by attending doctor |
Related Information
| Primary Sponsor | Nagoya Surgical Oncology Group |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Division of Surgical Oncology, Nagoya University Graduate School of Medicine |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Keisuke Uehara |
| Address | Japan |
| Telephone | |
| kuehara@med.nagoya-u.ac.jp | |
| Affiliation | Nagoya University Graduate School of Medicine Division of Surgical Oncology |
| scientific contact | |
| Name | Masato Nagino |
| Address | 65 Tsurumai-cho Showa-ku Nagoya, 466-8550, Japan Japan |
| Telephone | |
| Affiliation | Nagoya University Graduate School of Medicine Division of Surgical Oncology |